Molecular diagnostics is a critical aspect of medical testing that focuses on detecting genomic variants to aid in the detection, diagnosis, classification, prognosis, and monitoring of response to therapy. It represents the convergence of laboratory medicine, genomics knowledge, and technological advancements in molecular genetics.

The Molecular Diagnostics department is dedicated to conducting molecular diagnostic tests targeting nucleic acid sequences relevant to various medical conditions. We offer a comprehensive range of tests at the forefront of molecular diagnostics, including the highly impactful RT-PCR tests.

RT-PCR, or Real-Time Polymerase Chain Reaction, is a method used to detect the presence of specific genetic material in pathogens, including viruses. This technique, originally employing radioactive isotopes, has evolved to use fluorescent dyes, enabling real-time monitoring of the amplification process. RT-PCR has become a cornerstone in detecting viruses like COVID-19, providing rapid and accurate results.

Our tests in the Molecular Diagnostics department cover a broad spectrum of conditions and pathogens, including but not limited to:

  • ANA (Antinuclear Antibody)
  • BCR/ABL Mutation
  • Chikungunya
  • CMV (Cytomegalovirus) Qualitative and Quantitative
  • Dengue
  • Dengue Chikungunya Combo
  • FISH Her2neu (Fluorescence in situ hybridization)
  • Fluorescent Treponemal Antibody (FTA)
  • H1N1 Swine flu
  • HBV (Hepatitis B Virus) DNA Qualitative and Quantitative
  • HCV (Hepatitis C Virus) Qualitative and Quantitative
  • HIV (Human Immunodeficiency Virus) Qualitative and Quantitative Viral Load
  • HLA B27
  • HPV (Human Papillomavirus) High risk
  • HSV (Herpes Simplex Virus) Qualitative and Quantitative
  • IHC (Immunohistochemistry) CD markers, CK-20, CK-7, ER-PR, ER-PR-Her2neu, Ki-67
  • Influenza A & B type
  • JAK-2 Mutation
  • MTB (Mycobacterium tuberculosis) Qualitative and Quantitative
  • SARS-CoV-2 (COVID-19)

These tests play a crucial role in diagnosing and managing various diseases, enabling personalized treatment strategies and contributing to improved patient outcomes. Our commitment to utilizing cutting-edge molecular diagnostic techniques ensures accurate and timely results, empowering healthcare professionals to make informed clinical decisions.